Ownership history in Lindbrook Capital, LLC · 7 quarters on record
This page tracks every 13F SEC filing in which Lindbrook Capital, LLC reported a position in PLIANT THERAPEUTICS INC COM (PLRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2024 Q4 | ADDED | 25 | +11 | +78.6% | 0.00% | $329 | $13.17 |
| 2024 Q3 | REDUCED | 14 | -123 | -89.8% | 0.00% | $157 | $11.21 |
| 2024 Q2 | ADDED | 137 | +87 | +174.0% | 0.00% | $1K | $10.75 |
| 2023 Q4 | REDUCED | 50 | -17 | -25.4% | 0.00% | $906 | $18.11 |
| 2023 Q3 | REDUCED | 67 | -157 | -70.1% | 0.00% | $1K | $17.34 |
| 2022 Q1 | REDUCED | 224 | -476 | -68.0% | 0.00% | $2K | $7.01 |
| 2021 Q3 | INITIATED | 700 | — | — | 0.00% | $12K | $16.88 |
As of 2025 Q4 — sorted by position size